Synergic Photosensitizers: A New Trend in Photodynamic Therapy
Journal:
Current Organic Chemistry
Volume:
9
Page:
813-821
Author(s):
Claure N. Lunardi and Antonio C. Tedesco
EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer Therapeutics
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
149-157
Author(s):
Renee C. Ireton and Jin Chen
Modulation of pRb/E2F Functions in the Regulation of Cell Cycle and in Cancer
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
159-170
Author(s):
Lucy L. Seville, Nita Shah, Andrew D. Westwell and Weng C. Chan
Molecularly Targeted Therapy for Gastrointestinal Cancer
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
171-193
Author(s):
Marcus W. Wiedmann and Karel Caca
Copper Lowering Therapy With Tetrathiomolybdate as an Antiangiogenic Strategy in Cancer
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
195-202
Author(s):
George J. Brewer
Matrix Metalloproteinases as Therapeutic Targets in Cancer
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
203-220
Author(s):
Pia Vihinen, Risto Ala-aho and Veli-Matti Kahari
New Target Antigens for Cancer Immunoprevention
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
221-228
Author(s):
P.- L. Lollini, G. Nicoletti, L. Landuzzi, C. De Giovanni and P. Nanni
Editorial [Hot Topic: ErbB Family and Downstream Signal Transduction Pathways as Targets for Anticancer Therapy (Guest Editor: F. Caponigro)]
Journal:
Current Drug Targets
Volume:
6
Page:
241-242
Author(s):
F. Caponigro
The ErbB Receptors and their Ligands in Cancer: An Overview
Journal:
Current Drug Targets
Volume:
6
Page:
243-257
Author(s):
N. Normanno, C. Bianco, L. Strizzi, M. Mancino, M. R. Maiello, A. De Luca, F. Caponigro and D. S. Salomon
Small Molecules with EGFR-TK Inhibitor Activity
Journal:
Current Drug Targets
Volume:
6
Page:
259-274
Author(s):
Joan Albanell and Pere Gascon